Ishikawa E - Search Results

1

Ishikawa E, Muragaki Y, Yamamoto T, Ohno T, Matsumura A. Ishikawa E, et al. Prog Neurol Surg. 2018;32:101-111. doi: 10.1159/000469684. Epub 2018 Jul 10. Prog Neurol Surg. 2018. PMID: 29990978 Review.

2

Pathological changes after autologous formalin-fixed tumor vaccine therapy combined with temozolomide for glioblastoma - three case reports -.

Sakamoto N, Ishikawa E, Yamamoto T, Satomi K, Nakai K, Sato M, Enomoto T, Morishita Y, Takano S, Ohno T, Tsuboi K, Matsumura A. Sakamoto N, et al. Among authors: ishikawa e. Neurol Med Chir (Tokyo). 2011;51(4):319-25. doi: 10.2176/nmc.51.319. Neurol Med Chir (Tokyo). 2011. PMID: 21515959 Free article.

3

Glioma immunotherapy with combined autologous tumor cell and endothelial cell vaccine in vivo.

Sakamoto N, Uemae Y, Ishikawa E, Takano S, Nakai K, Yamamoto T, Zaboronok A, Matsumura A. Sakamoto N, et al. Among authors: ishikawa e. Neurol Med Chir (Tokyo). 2012;52(4):194-201. doi: 10.2176/nmc.52.194. Neurol Med Chir (Tokyo). 2012. PMID: 22522329 Free article.

4

Adoptive cell transfer therapy for malignant gliomas.

Ishikawa E, Takano S, Ohno T, Tsuboi K. Ishikawa E, et al. Adv Exp Med Biol. 2012;746:109-20. doi: 10.1007/978-1-4614-3146-6_9. Adv Exp Med Biol. 2012. PMID: 22639163 Review.

5

Phase I/IIa trial of fractionated radiotherapy, temozolomide, and autologous formalin-fixed tumor vaccine for newly diagnosed glioblastoma.

Ishikawa E, Muragaki Y, Yamamoto T, Maruyama T, Tsuboi K, Ikuta S, Hashimoto K, Uemae Y, Ishihara T, Matsuda M, Matsutani M, Karasawa K, Nakazato Y, Abe T, Ohno T, Matsumura A. Ishikawa E, et al. J Neurosurg. 2014 Sep;121(3):543-53. doi: 10.3171/2014.5.JNS132392. Epub 2014 Jul 4. J Neurosurg. 2014. PMID: 24995786 Clinical Trial.

6

[Intraoperative BCNU Wafer Implantation for High-Grade Glioma--A Questionnaire Targeting Japanese Neurosurgeons].

Ishikawa E, Yamamoto T. Ishikawa E, et al. Gan To Kagaku Ryoho. 2016 May;43(5):603-7. Gan To Kagaku Ryoho. 2016. PMID: 27210091 Japanese.

7

Prospect of Immunotherapy for Glioblastoma: Tumor Vaccine, Immune Checkpoint Inhibitors and Combination Therapy.

Ishikawa E, Yamamoto T, Matsumura A. Ishikawa E, et al. Neurol Med Chir (Tokyo). 2017 Jul 15;57(7):321-330. doi: 10.2176/nmc.nmc.ra.2016-0334. Epub 2017 May 24. Neurol Med Chir (Tokyo). 2017. PMID: 28539528 Free PMC article. Review.

8

Clinical trial of autologous formalin-fixed tumor vaccine for glioblastoma multiforme patients.

Ishikawa E, Tsuboi K, Yamamoto T, Muroi A, Takano S, Enomoto T, Matsumura A, Ohno T. Ishikawa E, et al. Cancer Sci. 2007 Aug;98(8):1226-33. doi: 10.1111/j.1349-7006.2007.00518.x. Epub 2007 May 22. Cancer Sci. 2007. PMID: 17517052 Free PMC article. Clinical Trial.

9

Early Postoperative Expansion of Parenchymal High-intensity Areas on T2-weighted Imaging Predicts Delayed Cerebral Edema Caused by Carmustine Wafer Implantation in Patients with High-grade Glioma.

Masuda Y, Ishikawa E, Yamamoto T, Matsuda M, Akutsu H, Kohzuki H, Nakai K, Okamoto E, Takano S, Masumoto T, Matsumura A. Masuda Y, et al. Among authors: ishikawa e. Magn Reson Med Sci. 2016 Jul 11;15(3):299-307. doi: 10.2463/mrms.mp.2015-0054. Epub 2015 Dec 28. Magn Reson Med Sci. 2016. PMID: 26726015 Free PMC article.

10

Immunohistochemistry on IDH 1/2, ATRX, p53 and Ki-67 substitute molecular genetic testing and predict patient prognosis in grade III adult diffuse gliomas.

Takano S, Ishikawa E, Sakamoto N, Matsuda M, Akutsu H, Noguchi M, Kato Y, Yamamoto T, Matsumura A. Takano S, et al. Among authors: ishikawa e. Brain Tumor Pathol. 2016 Apr;33(2):107-16. doi: 10.1007/s10014-016-0260-x. Epub 2016 Mar 11. Brain Tumor Pathol. 2016. PMID: 26968173

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,087 results

Search Page

Filters